Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AccuFFRangio Plus

K-Number: K230303 · 2023-03-02

Decision Date2023-03-02
Product CodeQHA
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

AccuFFRangio Plus is a medical device manufactured by ArteryFlow Technology Co., Ltd.. It received FDA 510(k) clearance on 2023-03-02 under approval number K230303. The device is classified under product code QHA. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AccuFFRangio Plus?

AccuFFRangio Plus is a medical device that received FDA 510(k) clearance on 2023-03-02. It is manufactured by ArteryFlow Technology Co., Ltd.. The 510(k) number is K230303.

When was AccuFFRangio Plus approved by the FDA?

AccuFFRangio Plus received FDA 510(k) clearance on 2023-03-02, under approval number K230303.

What company makes AccuFFRangio Plus?

AccuFFRangio Plus is manufactured by ArteryFlow Technology Co., Ltd..

What is the FDA product code for AccuFFRangio Plus?

The FDA product code for AccuFFRangio Plus is QHA.

Other Devices by ArteryFlow Technology Co., Ltd.

Related Devices (Code: QHA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.